CompletedNot Applicable

Dexmedetomidine Versus Fentanyl as an Adjuvant to Bupivacaine in Saddle Block

Egypt58 participantsStarted 2021-04-03

Plain-language summary

Dexmedetomidine is recommended over fentanyl as adjunctive medication to bupivacaine for saddle block spinal anesthesia in anal surgeries and procedures.

Who can participate

Age range20 Years – 60 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * both sexes * aged between 20 and 60 * classified as II \& ASA-I * scheduled for elective anal surgeries Exclusion Criteria: * subjects who refused to participate * uncontrolled hypertension * BMI \> 30 kg/m2 * heart failure (class IV or III) based on the New York Heart Association (NYHA) * uncorrected coagulopathy * any study's drug allergy * drug abuse * neuropathy * any spinal anesthesia contraindication (such as infection or a pelvic fracture)

What they're measuring

the duration until the first call for analgesia

Timeframe: 20 months

Trial details

NCT IDNCT06216197

SponsorZulekha Hospitals

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2022-12-04

View on ClinicalTrials.gov More Regional Anesthesia Morbidity trials